Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) Equity Ratio (2016 - 2025)

Angiodynamics (ANGO) has disclosed Equity Ratio for 15 consecutive years, with 0.65 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio changed N/A year-over-year to 0.65, compared with a TTM value of 0.65 through Nov 2025, changed N/A, and an annual FY2025 reading of 0.65, up 0.92% over the prior year.
  • Equity Ratio was 0.65 for Q4 2025 at Angiodynamics, down from 0.67 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.87 in Q3 2023 and bottomed at 0.65 in Q2 2024.
  • Average Equity Ratio over 5 years is 0.74, with a median of 0.74 recorded in 2022.
  • The sharpest move saw Equity Ratio grew 16.66% in 2023, then fell 8.88% in 2024.
  • Year by year, Equity Ratio stood at 0.78 in 2021, then dropped by 6.34% to 0.73 in 2022, then increased by 9.89% to 0.8 in 2023, then fell by 19.42% to 0.65 in 2024, then increased by 1.03% to 0.65 in 2025.
  • Business Quant data shows Equity Ratio for ANGO at 0.65 in Q4 2025, 0.67 in Q3 2025, and 0.65 in Q2 2025.